Targeting breast cancer stem cells: fishing season open!

Christophe Ginestier1, Emmanuelle Charafe-Jauffret, Daniel Birnbaum

  • 1Centre de Recherche en Cancérologie de Marseille, Laboratoire d'Oncologie Moléculaire, UMR Inserm/Institut Paoli-Calmettes, France. christophe.ginestier@inserm.fr

Insights

Cancer stem cells (CSCs) drive tumor growth and resistance. Targeting these cells offers a promising strategy for developing new cancer therapies and achieving a cure.

Area of Science:

  • Oncology
  • Cancer Biology
  • Stem Cell Research

Background:

  • The classical view of oncogenesis is evolving with the understanding of tumors as hierarchically organized cell populations.
  • Cancer stem cells (CSCs) are implicated in tumor initiation, maintenance, therapy resistance, and metastasis.

Purpose of the Study:

  • To highlight the critical role of CSCs in cancer progression and therapeutic resistance.
  • To underscore the importance of developing targeted therapies against CSCs for achieving a definitive cancer cure.

Main Methods:

  • Review of current research on CSC biology and therapeutic strategies.
  • Discussion of approaches for targeting CSCs, including pathway-based and high-throughput screening methods.

Main Results:

  • CSCs are essential for tumor initiation, maintenance, and recurrence.
  • Targeting CSCs is a key strategy for overcoming therapy resistance and preventing metastasis.

Conclusions:

  • Developing drugs that specifically target CSCs is crucial for effective cancer treatment.
  • Ongoing research focuses on identifying novel CSC targets and therapeutic compounds to improve patient outcomes.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...